Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126462191 | 12646219 | 1 | I | 2006 | 20160729 | 20160811 | 20160811 | PER | US-ASTRAZENECA-2016SE83742 | ASTRAZENECA | 66.00 | YR | M | Y | 104.30000 | KG | 20160812 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126462191 | 12646219 | 1 | PS | BYETTA | EXENATIDE | 1 | Subcutaneous | 10.0UG UNKNOWN | 21773 | 10 | UG | SUSPENSION FOR INJECTION IN PRE-FILLED PEN | |||||||
| 126462191 | 12646219 | 2 | SS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | Y | U | 0 | 20 | MG | TABLET | QD | |||||
| 126462191 | 12646219 | 3 | SS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | Y | U | 0 | 20 | MG | TABLET | QD | |||||
| 126462191 | 12646219 | 4 | SS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | Y | U | 0 | 10 | MG | TABLET | QD | |||||
| 126462191 | 12646219 | 5 | SS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | Y | U | 0 | 10 | MG | TABLET | QD | |||||
| 126462191 | 12646219 | 6 | C | ZYRTEC | CETIRIZINE HYDROCHLORIDE | 1 | Oral | 0 | |||||||||||
| 126462191 | 12646219 | 7 | C | COENZYME Q10 | UBIDECARENONE | 1 | Oral | 0 | |||||||||||
| 126462191 | 12646219 | 8 | C | VALSARTAN. | VALSARTAN | 1 | Oral | 0 | 320 | MG | QD | ||||||||
| 126462191 | 12646219 | 9 | C | TAMSULOSIN | TAMSULOSIN | 1 | Oral | 0 | .04 | MG | QD | ||||||||
| 126462191 | 12646219 | 10 | C | ALLOPURINOL. | ALLOPURINOL | 1 | Oral | 0 | 300 | MG | QD | ||||||||
| 126462191 | 12646219 | 11 | C | HYDROCHOLORITHIAZIDE | 2 | Oral | 0 | 24 | MG | QD | |||||||||
| 126462191 | 12646219 | 12 | C | OXYBUTIN | OXYBUTYNIN | 1 | Oral | 0 | 10 | MG | QD | ||||||||
| 126462191 | 12646219 | 13 | C | BABY ASPIRIN | ASPIRIN | 1 | Oral | DAILY | 0 | ||||||||||
| 126462191 | 12646219 | 14 | C | VITAMINS | VITAMINS | 1 | Oral | DAILY | 0 | ||||||||||
| 126462191 | 12646219 | 15 | C | FENESTERIDE | 2 | Oral | 0 | 5 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126462191 | 12646219 | 1 | Blood glucose abnormal |
| 126462191 | 12646219 | 2 | Ill-defined disorder |
| 126462191 | 12646219 | 3 | Blood cholesterol increased |
| 126462191 | 12646219 | 4 | Ill-defined disorder |
| 126462191 | 12646219 | 5 | Blood cholesterol increased |
| 126462191 | 12646219 | 6 | Multiple allergies |
| 126462191 | 12646219 | 8 | Blood pressure abnormal |
| 126462191 | 12646219 | 9 | Micturition disorder |
| 126462191 | 12646219 | 10 | Blood uric acid abnormal |
| 126462191 | 12646219 | 12 | Biopsy prostate |
| 126462191 | 12646219 | 14 | Cataract |
| 126462191 | 12646219 | 15 | Dysuria |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126462191 | 12646219 | Decreased appetite | |
| 126462191 | 12646219 | Muscle spasms | |
| 126462191 | 12646219 | Nausea | |
| 126462191 | 12646219 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126462191 | 12646219 | 1 | 2006 | 0 | ||
| 126462191 | 12646219 | 2 | 2006 | 2015 | 0 | |
| 126462191 | 12646219 | 3 | 2006 | 2015 | 0 | |
| 126462191 | 12646219 | 4 | 2015 | 0 | ||
| 126462191 | 12646219 | 5 | 2015 | 0 | ||
| 126462191 | 12646219 | 9 | 2006 | 0 | ||
| 126462191 | 12646219 | 10 | 2006 | 0 | ||
| 126462191 | 12646219 | 11 | 2006 | 0 | ||
| 126462191 | 12646219 | 12 | 2006 | 0 | ||
| 126462191 | 12646219 | 15 | 2006 | 0 |